首页 | 本学科首页   官方微博 | 高级检索  
     

环氧化物水解酶1基因多态性对华法林剂量影响的研究
引用本文:罗万慰a,张海燕a,马守梅b,许联红c,张中行a,杨协清a. 环氧化物水解酶1基因多态性对华法林剂量影响的研究[J]. 中国药学杂志, 2010, 45(19): 1488-1491
作者姓名:罗万慰a  张海燕a  马守梅b  许联红c  张中行a  杨协清a
作者单位:江苏大学附属武进医院,a.药剂科;b.心胸外科;c.中心实验室, 江苏 常州 213002
摘    要: 目的 探讨苏南地区心脏机械瓣膜置换术后汉族人群环氧化物水解酶1(EPHX1)基因rs4653436和rs2292566多态性对华法林剂量的影响,为以后利用基因多态性指导临床合理用药提供理论依据。方法 采用碱基淬灭探针技术,检测197名心脏机械瓣膜置换术后患者的EPHX1 rs4653436和EPHX1 rs2292566的基因型,分析对华法林剂量的影响。结果 EPHX1基因 rs4653436多态性检测有127例纯合子GG型,62例患者为AG型杂合子,8例突变纯合子AA型; GG型患者华法林的平均稳定剂量为(2.64±0.93) mg·d-1, AG型为(2.52±0.68) mg·d-1,AA型为(3.25±1.63) mg·d-1,采用方差分析方法得到各组间华法林剂量差异P值大于0.05,无显著性差异;而EPHX1基因 rs2292566多态性检测有107例纯合子GG型,70例AG型杂合子,20例突变纯合子AA型; GG型患者华法林的平均稳定剂量为(2.47±0.85) mg·d-1,AG型为(2.49±0.77)mg·d-1,AA型为(2.81±0.96)mg·d-1,方差分析方法得到各组间华法林剂量差异P值小于0.05,有显著性差异。结论 在苏南地区心脏机械瓣膜置换术后汉族人群中,EPHX1基因 rs4653436多态性与华法林剂量相关性无显著性差异,对华法林剂量影响较小;而rs2292566多态性与华法林剂量相关性有显著性差异,对华法林剂量有影响。

关 键 词:环氧化物水解酶1  华法林  基因多态性
收稿时间:2012-01-01;

Effect of the Epoxide Hydrolase 1 Gene Polymerphism on Warfarin Dose
LUO Wan-weia,ZHANG Hai-yana,MA Shou-meib,XU Lian-hongc,ZHANG Zhong-xinga,YANG Xie-qinga. Effect of the Epoxide Hydrolase 1 Gene Polymerphism on Warfarin Dose[J]. Chinese Pharmaceutical Journal, 2010, 45(19): 1488-1491
Authors:LUO Wan-weia  ZHANG Hai-yana  MA Shou-meib  XU Lian-hongc  ZHANG Zhong-xinga  YANG Xie-qinga
Affiliation:a.Department of Pharmacy;b.Department of Cardiothoracic Surgery;c.Central Laboratory, Affiliated Wujin Hospital of Jiangsu University ,Changzhou 213002, China
Abstract:OBJECTIVE To investigate the effect of EPHX1 rs4653436 and rs2292566 polymorphism on warfarin maintenance dose in the Han population. METHODSThe single nucleotide polymorphism was detected using base-quenched probe technique. EPHX1 rs4653436 and rs2292566 polymorphisms were analyzed in 197 patients with mechanical heart valve replacement. RESULTS The genotype of EPHX1 rs4653436 showed that 127 patients were homozygous GG , 62 were heterozygous AG, and 8 were homozygous AA genotype. Warfarin doses were (2.64±0.93) mg·d-1 in patients with EPHX1 rs4653436 GG genotype, (2.52±0.68) mg·d-1 in AG genotype,and (3.25±1.63)mg·d-1 in AA genotype. ANOVA analysis showed EPHX1 rs4653436 showed no relationshiop with warfarin. However, the genotype of EPHX1 rs2292566 showed that 109 patients were homozygous GG , 70 were heterozygous AG, and 20 were homozygous AA genotype.Warfarin doses were (2.47±0.85) mg·d-1 in patients with EPHX1 rs2292566 GG genotype, (2.49±0.77) mg·d-1 in AG genotyp,and (2.81±0.96)mg·d-1 in AA genotype. EPHX1 rs2292566 showed significant relationship with warfarin. CONCLUSION EPHX1 rs4653436 showed no relationship with the dose of warfarin ,yet, EPHX1 rs2292566 show significant relatiopship with warfarin dose in the Han population of south Jiangsu province.
Keywords:EPHX1  warfarin  polymorphism
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号